2017 Specialty Drugs in the Pipeline: Oral Oncologics

Description

New oral oncologics are hitting the market in droves. With the potential for self-administration, these specialty medications are transforming treatment strategies for managing patients with cancer. Learn about therapeutic advances in new and emerging oral anticancer agents, and hear a panel discussion on the management of these agents from both the payer and provider perspectives.

Pharmacist Learning Objectives

At the completion of this knowledge-based activity, participants will be able to:

  1. Discuss clinical use of recently approved oral oncologic medications.
  2. Identify emerging oral oncologic therapies.
  3. Describe payer and provider strategies for appropriate management of oral oncologic medications.

Technician Learning Objectives

At the completion of this knowledge-based activity, participants will be able to:

  1. Discuss clinical use of recently approved oral oncologic medications.
  2. Identify emerging oral oncologic therapies.
  3. Describe payer and provider strategies for appropriate management of oral oncologic medications.
 
 
 
Speakers:
Robert
Robert Mancini,
Clinical Adjunct Instructor
Idaho State University
 
Scott
Scott Wirth,
UI Health
 
Learning Level: Level 1
Track: Specialty Pharmacy
Session Time Slot(s): 
Date: 
Sunday, March 18
Time: 
7:00 AM - 8:30 AM
Room: 
Music City Center - Room 101A-B
ACPE Pharmacist: 0202-0000-18-036
CEUs Pharmacist: 0.15
ACPE Pharmacy Technician: 0202-0000-18-036
CEUs Pharmacy Technician: 0.15
Activity Type:
Knowledge-based